Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway

Oral squamous cell carcinoma (OSCC) is a malignant tumour originating from the mucosal lining of the oral cavity. Its characteristics include hidden onset, high recurrence, and distant metastasis after operation. At present, clinical treatment usually includes surgery, chemotherapy, radiotherapy, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yunfei, Lin, Jing, Duan, Meng, Rui, Ying, Zheng, Hao, Zhu, Liting, Zhu, Xuanyu, Wei, Jingchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674064/
https://www.ncbi.nlm.nih.gov/pubmed/34926131
http://dx.doi.org/10.1155/2021/5228713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674064/
https://www.ncbi.nlm.nih.gov/pubmed/34926131
http://dx.doi.org/10.1155/2021/5228713

Ejemplares similares